Linezolid resistance in multidrug-resistant mycobacterium tuberculosis: A systematic review and meta-analysis

Introduction: Linezolid (LNZ) is an effective antibiotic to treat patients with multidrug-resistant tuberculosis (MDR-TB) treatment failure. M. tuberculosis strains resistant to isoniazid and rifampin are defined as MDR-TB. In recent years, resistance to LNZ among MDR-TB cases has been reported in s...

Descripción completa

Detalles Bibliográficos
Autores principales: Azimi, Taher, Khoshnood, Saeed, Asadi, Arezoo, Heidary, Mohsen, Mahmoudi, Hassan, Kaviar, Vahab Hassan, Hallajzadeh, Masoume, Nasiri, Mohammad Javad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9468755/
https://www.ncbi.nlm.nih.gov/pubmed/36110536
http://dx.doi.org/10.3389/fphar.2022.955050

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9468755/
https://www.ncbi.nlm.nih.gov/pubmed/36110536
http://dx.doi.org/10.3389/fphar.2022.955050

Ejemplares similares